IGC Pharma, Inc. (IGC) › Shareholders' EquityIGC Pharma, Inc. (IGC) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2011: $6.67M2012: $14.84M2013: $14.44M2014: $13.63M2015: $14.23M2016: $13.48M2017: $7.36M2018: $8.06M2020: $26.54M2021: $32.80M2022: $23.89M2023: $14.91M2024: $7.32M2025: $7.42M$7.42M2011Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$7.42M+1.4%2024$7.32M-50.9%2023$14.91M-37.6%2022$23.89M-27.2%2021$32.80M+23.6%2020$26.54M—2018$8.06M+9.6%2017$7.36M-45.4%2016$13.48M-5.3%2015$14.23M+4.5%2014$13.63M-5.6%2013$14.44M-2.7%2012$14.84M+122.6%2011$6.67M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share